PERK, Beyond an Unfolded Protein Response Sensor in Estrogen-Induced Apoptosis in Endocrine-Resistant Breast Cancer
Authors:
Open Access
- 1 February 2022
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Research
- Vol. 20 (2) , 193-201
Abstract
The discovery of 17β-estradiol (E2)–induced apoptosis has clinical relevance. Mechanistically, E2 over activates nuclear estrogen receptor α that results in stress responses. The unfolded protein response (UPR) is initiated by E2 in the endoplasmic reticulum after hours of treatment in endocrine-resistant breast cancer cells, thereby activating three UPR sensors—PRK-like endoplasmic reticulum kinase (PERK), inositol-requiring enzyme 1α (IRE1α), and activating transcription factor 6 (ATF6) with different functions. Specifically, PERK plays a critical role in induction of apoptosis whereas IRE1α and ATF6 are involved in the endoplasmic reticulum stress-associated degradation (ERAD) of PI3K/Akt/mTOR pathways. In addition to attenuating protein translation, PERK increases the DNA-binding activity of NF-κB and subsequent TNFα expression. In addition, PERK communicates with the mitochondria to regulate oxidative stress at mitochondria-associated endoplasmic reticulum membranes (MAM). Furthermore, PERK is a component enriched in MAMs that interacts with multifunctional MAM-tethering proteins and integrally modulates the exchange of metabolites such as lipids, reactive oxygen species (ROS), and Ca2+ at contact sites. MAMs are also critical sites for the initiation of autophagy to remove defective organelles and misfolded proteins through specific regulatory proteins. Thus, PERK conveys signals from nucleus to these membrane-structured organelles that form an interconnected network to regulate E2-induced apoptosis. Herein, we address the mechanistic progress on how PERK acts as a multifunctional molecule to commit E2 to inducing apoptosis in endocrine-resistant breast cancer.Keywords
Funding Information
- NIH NCI (P30-CA016672)
- Susan G. Komen (SAC100009)
This publication has 89 references indexed in Scilit:
- mTOR complex 2-Akt signaling at mitochondria-associated endoplasmic reticulum membranes (MAM) regulates mitochondrial physiologyProceedings of the National Academy of Sciences, 2013
- Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trialThe Lancet Oncology, 2012
- Oxidative protein folding in the endoplasmic reticulum: Tight links to the mitochondria-associated membrane (MAM)Biochimica et Biophysica Acta (BBA) - Biomembranes, 2010
- Essential Regulation of Cell Bioenergetics by Constitutive InsP3 Receptor Ca2+ Transfer to MitochondriaCell, 2010
- Mitochondria Supply Membranes for Autophagosome Biogenesis during StarvationCell, 2010
- A subdomain of the endoplasmic reticulum forms a cradle for autophagosome formationNature Cell Biology, 2009
- Lower-Dose vs High-Dose Oral Estradiol Therapy of Hormone Receptor–Positive, Aromatase Inhibitor–Resistant Advanced Breast CancerJAMA, 2009
- Mitofusin 2 tethers endoplasmic reticulum to mitochondriaNature, 2008
- Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancerSteroids, 2007
- Tamoxifen: a most unlikely pioneering medicineNature Reviews Drug Discovery, 2003